两大全球战略研发中心加持,覆盖医药研发全链条

生物谷
Sep 24

近年来,阿斯利康全球研发在中国不断快速发展,从2019年全球研发中心在上海的设立,到2024年上海中心升级为全球战略研发中心,2025年初宣布在北京设立全球第六大战略研发中心,阿斯利康全球研发中国在全球研发战略中,占据了举足轻重的地位。目前,阿斯利康全球研发中国团队人员已增至1200多人,中国研发管线项目与全球同步率为100%,正在与全国近500家医院,进行160多个临床项目,早期临床研发项目占...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10